evidencegaps
Primary study · included by 1 review

Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.

Le Roux 2020 · Le Roux Marc-Kevin, Graillon Nicolas, Guyot Laurent, et al. · Head & neck · 2020

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Le Roux 2020 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · more than 1 year after RIT
Prevalence 0.17 [0.10, 0.28]6 studies · 1005 participantsGRADE not reported

1 including review in total.